A study for a 61 year old woman who takes Janumet - from FDA reports


Summary

1,259 females aged 61 (±5) who take the same drug are studied. This is a personalized study for a 61 year old female patient who has Diabetic Type 2. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Aug, 11, 2017

1,259 females aged 61 (±5) who take Janumet are studied.


Number of reports submitted per year:

Janumet for a 61-year old woman.

Information of the patient in this study:

  • Age: 61
  • Gender: female
  • Conditions: Diabetic Type 2
  • Drugs taken:
    • Janumet (metformin hydrochloride; sitagliptin phosphate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Canker Sores: 0 (0% of females aged 61 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

n/a

Top conditions involved for these people *:

  • High Blood Pressure (218 people, 17.32%)
  • High Blood Cholesterol (138 people, 10.96%)
  • Rheumatoid Arthritis (55 people, 4.37%)
  • Depression (39 people, 3.10%)
  • Hypothyroidism (38 people, 3.02%)

Top co-used drugs for these people *:

  • Metformin (106 people, 8.42%)
  • Lantus (92 people, 7.31%)
  • Crestor (85 people, 6.75%)
  • Synthroid (79 people, 6.27%)
  • Januvia (77 people, 6.12%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Related studies:

Can you answer these questions?

More questions for: Canker sores, Janumet, Diabetic type 2

You may be interested in these reviews

More reviews for: Canker sores, Janumet, Diabetic type 2